Wnt binding to cell surface receptors can activate a 'canonical' pathway that increases cellular b-catenin or a 'noncanonical' Ca CC pathway which can increase protein kinase C (PKC) activity. Although components of both Wnt/b-cateninsignaling pathways exist in thyrocytes, their biological role is largely unknown. In evaluating the biological role of Wnt signaling in differentiated FRTL-5 thyroid cells, we showed that TSH increased canonical Wnt-1 but, surprisingly, decreased the active form of b-catenin. In addition, these final results suggest that TSH-induced increase in Wnt-1 levels in thyrocytes contributes to enhanced cellular growth via a PKC pathway that increases STAT3 serine phosphorylation and activation, whereas TSH-induced decrease in activation of bcatenin simultaneously relieves transcriptional suppression of TPO. We hypothesize that Wnt signaling contributes to the ability of TSH to simultaneously increase cell growth and functional, thyroid-specific, gene expression.
Introduction
Wnt proteins are major signaling molecules involved in embryonic induction, generation of cell polarity, and cell fate decisions, as evidenced in studies with C. elegans, Drosophila, and mice (Cadigan & Nusse 1997) . Over the past two decades, the 19 members of the Wnt protein family that have been found in mammals, have all been shown to be cysteinerich glycoproteins that act as short-range ligands to i) locally activate receptor-mediated signaling pathways in a spatially restricted, yet dynamic expression pattern, both in embryos and adults, and ii) to be powerful regulators of cell proliferation and differentiation . A central player in Wnt-signaling pathways is b-catenin (Nelson & Nusse 2004) . b-Catenin, a transcription cofactor that acts together with T cell factor/lymphoid enhancing factor (TCF/LEF) to induce target gene expression (Cadigan & Nusse 1997) , is a structural adaptor protein linking cadherins to the actin cytoskeleton in cell-to-cell adhesion (Gumbiner 2000 , Jamora & Fuchs 2002 .
Upon secretion from cells, Wnt ligands bind to two receptor molecules: frizzled proteins and lipoprotein-related protein 5 and 6. The binding activates multiple signaling pathways including the 'Wnt/b-catenin' pathway, the 'Wnt/Ca CC ' pathway and the 'planar cell polarity' pathway (Cadigan & Nusse 1997 , Miller et al. 1999 , Nelson & Nusse 2004 . Amongst these, the best known and most extensively studied is the 'Wnt/b-catenin' pathway, often termed the 'canonical Wnt pathway', which regulates the cellular level of b-catenin. In the absence of Wnt signaling, b-catenin levels are low due to proteasome-mediated degradation. The b-catenin is targeted for ubiquitination and degradation in the 26S proteasome by paired phosphorylation through the serine/threonine kinases, casein kinase I, and glycogen synthase kinase-3b (GSK-3b), which are both bound to a scaffolding complex of axin and adenomatous polyposis coli protein (Polakis 2000 (Polakis , 2002 . Activation of Wnt signaling decreases GSK-3b-mediated phosphorylation of b-catenin. This results in the accumulation of cytoplasmic b-catenin, which can bind the TCF/LEF transcription factors and induce the transcription of multiple target genes. The transcription of c-myc and cyclin D1, two target genes of b-catenin, which are linked to growth, is increased by b-catenin in colon cancer cells (Behrens et al. 1996 , Tetsu & McCormick 1999 . Wnt signaling can also trigger the 'Wnt/Ca CC ' pathway, which activates Ca CC release and protein kinase C (PKC; Miller et al. 1999) . How each pathway is preferentially activated is not clear, although the subtype of frizzled protein receptor expressed on the cell may be the main determinant (Sheldahl et al. 1999) .
Knowledge of Wnt/b-catenin signaling is important for understanding pathologic cellular growth such as cancer (Polakis 2000) . Indeed, activation of the canonical Wntsignaling pathway has been observed in several types of cancers (Polakis 1997 , Morin 1999 , Clevers 2000 , Webster et al. 2000 . Additionally, mutations in the b-catenin gene (CTNNb1), which affects serine and threonine residues that are essential for the targeted degradation of b-catenin, have been observed in a wide variety of human cancers, as well as in chemically or genetically induced animal tumors (Polakis 2000) . In contrast, little is known about the role of noncanonical Wnt/Ca CC -signaling pathway in pathological or physiological cell growth.
Components of the Wnt/b-catenin-signaling pathway, i.e. multiple Wnt, Frizzled and the signaling adaptor, Disheveled have been shown to be expressed in human thyroid cells (Helmbrecht et al. 2001) . Moreover, several studies have demonstrated dysregulation of Wnt/b-catenin pathway in thyroid neoplasms exhibiting both abnormal growth and loss of thyrocyte function (Cerrato et al. 1998 , Garcia-Rostan et al. 1999 , Huang et al. 1999 . These observations suggest that the Wnt/b-catenin-signaling pathway may be involved in the physiologic and pathologic control of thyroid cell growth and function; however, the biological role of the Wnt/b-catenin-signaling pathway is currently not known in normal thyrocytes.
FRTL-5 cells are a continuously growing rat thyroid cell line and have a differentiated phenotype, since they express thyroid-specific or restricted genes, such as the thyroperoxidase (TPO), thyroglobulin (Tg), sodium iodide symporter, and the thyroid-stimulating hormone receptor (TSHR) genes, all of which are under the regulatory control of TSH and insulin/insulin-like growth factor-I (IGF-I). Moreover, the growth of FRTL-5 cells is regulated by several hormones including TSH, insulin and/or IGF-I (Bidey et al. 1988 , Kohn et al. 1989 . Importantly, FRTL-5 cells do not exhibit characteristics of tumor cells in vitro or when transplanted in vivo.
In this study, we used the FRTL-5 cells to evaluate the biological role of Wnt-signaling pathways in thyrocytes. We found that Wnt-1 is expressed in FRTL-5 cells and upregulated by TSH, whereas active b catenin (ABC) is downregulated by TSH. Transiently and stable overexpressing of Wnt-1 and b-catenin revealed unexpectedly that i) activation of the Wnt-1 ligand/receptor pathway can enhance cellular growth through a noncanonical signal involving PKC and increased serine phosphorylation of signal transducers and activators of transcription 3 (STAT3), whereas ii) activation of the canonical b-catenin pathway suppresses transcription of the TPO gene via its interaction with TCF/LEF-binding site upstream of the thyroid transcription factor (TTF)-1, Pax-8, and TTF-2 sites on the rat TPO promoter. We hypothesize that TSH-induced increase in Wnt-1 may be important for upregulation of a noncAMP-mediated thyroid growth signal. The coincident and surprising TSH-induced decrease in b-catenin levels may result in relief of b-catenin-mediated suppression of at least one critical functional gene, the TPO gene, needed for iodination of Tg. 
Materials and Methods

Reagents and chemicals
Expression vectors and reporter genes
Empty expression vector (pCS2C), mouse Wnt-1 cDNA cloned into pCS2C (Wnt-1/CS2C), human b-catenin cDNA with myc tag sequence in pCS2CMT vector (MTbCat), human b-catenin cDNA with TAP tag sequence in pIRES PURO vector (bCat), mouse Wnt-1 cDNA cloned into pVITRO3-mcs (pVITRO3/Wnt-1) have been previously described (McMahon & Moon 1989 , Yang-Snyder et al. 1996 , Yost et al. 1996 , Emami et al. 2004 . Since pVITRO3-mcs has the hygromycin-resistance gene (hph), pVITRO3/Wnt-1 was used for making stable transfectants with FRTL-5 cells. Control vector for b Cat (pIRES-PURO) was made by cutting out the b-catenin cDNA fragment with EcoRV/BamHI and by re-ligation of vector fragment. Similarly, the control vector for pVITRO3/Wnt-1 (pVITRO3) was made by cutting out the Wnt-1 cDNA fragment by EcoRI and by re-ligation of vector fragment. Human TPO-promoter-luciferase constructs of various lengths from the transcription start site (pSV0/TPO-181 pSV/TPO-1372 pSV/TPO-6300 pSV) have been previously described (Kikkawa et al. 1990 , Mizuno et al. 1991 , Suzuki et al. 1998 . SuperTOPFlash reporter, luciferase reporter vector containing multiple TCF/LEF-binding sites and its negative control vector SuperFOP vector were previously described (Kaykas et al. 2004) .
Cell culture and establishment of stably transfected cell lines
The F1 subclone of FRTL-5 rat thyroid cells (Interthyr Research Foundation, Baltimore, MD, USA) was grown in Coon's modified F-12 medium supplemented with 5% heat inactivated calf serum, 1 mM nonessential amino acid, and a mixture of six hormones (6H) including TSH, insulin, cortisol, transferrin, glycyl-L-histidyl-L-lysine acetate, and somatostatin (Shimura et al. 1994 , Saji et al. 1997 . In some experiments, FRTL-5 cells were fed 5H medium (i.e. 6H medium without TSH) for 5-6 days prior to the day of the experiment.
FRTL-5 cells stably overexpressing Wnt-1 protein were established using the electroporation method. Briefly, FRTL-5 cells grown in 6H media were harvested. Mammalian expression vector for Wnt-1 (pVITRO3/Wnt-1) or empty vector (pVITRO3) were prepared and cell suspension (10! 10 6 cells/ml) was mixed with 30 mg plasmid in a cuvette and electroporated at 300 V (capacitance at 960 mF) using Gene Pulser (Bio-Rad Laboratories). Individual clones were selected and maintained in the presence of 200 mg/ml hygromycin B (Invitrogen). Clones were screened and selected based on Wnt-1 expression level.
Transient transfection of FRTL-5 cells
Transient transfection of Fischer rat thyroid cells in low serum, chronically expressed to 5% serum (FRTL-5) cells was carried out using DEAE-dextran (ProFection Mammalian Transfection System, Promega) according to the manufacturer's instruction. Briefly, cells were grown in 6H medium until 40-50% confluency and subsequently maintained in 5H medium for 5-6 days. A day prior to transfection, the cells were again fed with 6H medium. Twenty micrograms plasmid were used for an transfection of 1 dish of cells. After transfection, cells were grown in 6H medium for an additional 48-72 h to be harvested for total RNA or cell lysate preparation.
LiCl is a known GSK-3 inhibitor (Klein & Melton 1996) which leads to accumulation of b-catenin in cells. The optimal concentration of LiCl for inducing b-catenin accumulation was 2 mM (data not shown); concentrations higher than 2 mM were cytotoxic (data not shown).
Luciferase assay
The effects of b-catenin or Wnt-1 overexpression on TPOpromoter activities were evaluated using luciferase assay. FRTL-5 cells were transfected with 100 ng various TPO-promoter-luciferase constructs (pSV0/TPO-181 pSV/TPO-1372 pSV/TPO-6300 pSV) and 1 mg b-catenin or Wnt-1 expression vector using DEAE-dextran solution. Cells were lysed after 48 h, and luciferase activity was measured using luciferase assay system (Promega) and a LUMAT LB 9507 luminometer (Berthold GmbH & Co. KG, Bad Wildbad, Germany) . Data presented were normalized to protein concentration of cell lysate.
Western blot analysis
Cells were lysed in lysis buffer (50 mM Tris-HCl (pH 8 . 0), 150 mM NaCl, and protease inhibitor cocktail (EMD Biosciences Inc. San Diego, CA, USA)). The lysate was sheared by sonic dismembrator and quantified using micro bicinchoninic acid (BCA) protein assay kit (Pierce, Rockford, IL, USA). Twenty micrograms lysate were resolved on NuPAGE Bis-Tris gel (Invitrogen) and transferred to nitrocellulose membrane. Membranes were immunoblotted with specific antibodies and revealed using enhanced chemiluminescent (ECL) western blot detecting system (Amersham Biosciences). The antibodies were against b-catenin (7963, Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA), ABC (05-665, Upstate Biotechnology Inc., Lake Placid, NY, USA), total STAT3 (06-596, Upstate Biotechnology Inc.), STAT3 phosphorylated on Tyr705 (9131S, Cell Signaling Technology, Beverly, MA, USA), STAT3 phosphorylated on Ser727 (44-384G, Biosource International Inc., Camarillo, CA, USA), Wnt-1 (36-5800, Zymed Laboratories Inc., South San Francisco, CA, USA), or b-actin (4967, Cell Signaling Technology). ABC antibodies recognize b-catenin, which is dephosphorylated on Ser37 and Thr41 (van Noort et al. 2002) .
RNA isolation and northern blot analysis
Northern blot analysis was performed as previously described (Suzuki et al. 1999) . Twelve micrograms total RNA per lane were resolved in 1% denaturing agarose gels containing 0 . 66 M formaldehyde and transferred onto Nytran membranes, UV cross-linked and hybridized with specific probes. The probes for rat Tg, TPO, TSHR (Isozaki et al. 1989 , Fabbro et al. 1994 , Shimura et al. 1994 , Saji et al. 1997 , Suzuki et al. 1998 , and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) have been described (Suzuki et al. 1999) . The probe for Wnt-1 was obtained from mouse Wnt-1 expression vector. Probes were labeled with a-32 P-dCTP using the Ladderman Labeling Kit (Takara Biochemical Inc.; Berkeley, CA, USA). Northern blots were developed using a BAS 1500 Bioimaging Analyzer (Fuji Photo Film Co. Ltd Medical Systems USA Inc., Stamford, CT, USA).
Nuclear extracts and electrophoretic mobility shift assay (EMSA)
Nuclear extracts were prepared from harvested FRTL-5 cells using NE-PER nuclear and cytoplasmic extraction reagents (Pierce) in the presence of a protease inhibitor cocktail (phenylmethylsulfonyl fluoride, Leupeptin, Pepstatin-A). Double-stranded DNA corresponding to bases K145 out of K123 of the rat TPO-promoter ) was end labeled with [g-32 P] ATP using T4 polynucleotide kinase. Binding reaction for TCF/LEF EMSA (30 min, room temperature) included 32 P-labeled probe (activity 100 000 cpm), 10 mg NE of Wnt-1/b-catenin-transfected cells, 0 . 05 mg poly (dI-dC), 2 mM DTT, 2 . 5% glycerol, 0 . 05% NP-40, 40 mM Tris-HCl (pH 7 . 5), 200 mM NaCl, and 5 mM MgCl 2 . After the incubations, reaction mixtures were electrophoresed on 5% native polyacrylamide gels and autoradiographed. The DNA sequence of the oligonucleotide used as DNA probe (top strand only) for TCF/LEF-binding site on rat TPO-promoter was 5 0 -AGTGGCACCTTTGTTCT-GACCAG-3 0 . Antibody specific for TCF-1 was from Santa Cruz Biotechnology Inc.
Cell growth assay
Cell growth was measured using (3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide) (MTT) assay (Mosmann 1983) . Cells were plated at 2!10 4 cells/well in 24-well plates and incubated for the indicated times. At each time period, 50 ml 1 mg/ml MTT solution were added to each well with 3 h incubation and 500 ml 10% Triton-X in isopropyl alcohol was added to dissolve the converted dye. The absorbance of solution from each well was measured at 570 nm. Value measured 3 h after plating was considered as baseline.
Flow cytometric analysis of cell cycle
Cells at 80-90% confluency were harvested, washed, and resuspended in PBS; ice-cold ethanol was added to the cell suspensions. Samples were stored at 4 8C until the day of analysis. On the day of analysis, samples were washed and incubated with PBS solution containing ribonuclease A (3 mg/ml) and propidium iodide (0 . 05 mg/ml) for 15 min at 37 8C in dark. Cells were analyzed using a FACSort flow cytometer (Becton Dickinson, San Jose, CA, USA). The area of the red fluorescence voltage pulse for the cells is proportional to its DNA content.
Statistical analysis
Mann-Whitney U test (SPSS 13.0; SPSS Inc., Chicago, IL, USA) was used to assess statistical differences between two groups. Unless stated otherwise, all error bars represent S.D.
Results
TSH increases endogenous Wnt-1 expression, but decreases ABC levels, in FRTL-5 thyroid cells
Initially, we investigated the basal expression and the effects of TSH on expression of selected Wnts in FRTL-5 thyroid cells. FRTL-5 thyrocytes were cultured in the presence or absence of TSH. Subsequently, the mRNA and the protein levels of Wnts were assessed using northern-and western blot analyses. As shown in Fig. 1 , Wnt-1 mRNA (Fig. 1a ) and protein levels (Fig. 1b) in FRTL-5 thyrocytes were significantly increased in the presence of TSH (CTSH lane). In contrast, Wnt-5a expression levels were not significantly affected by the presence of TSH (data not shown). Of note, FRTL-5 cells did not express WnT-3a (data not shown). Thus, TSH appears to specifically upregulate Wnt-1 levels in FRTL-5 cells.
Wnt-1 is known to increase the intracellular amount of b-catenin through the inhibition of its degradation (Cadigan & Nusse 1997, Miller et al. 1999 , Nelson & Nusse 2004 . When FRTL-5 cells were transfected with Wnt-1, Wnt-3a, or Wnt-5a expression vectors, an increase in ABC level was most prominent with Wnt-1 overexpression (Fig. 2a, lower panel, arrow) . Total b-catenin was at best slightly increased only with Wnt-1 overexpression (Fig. 2a,  upper panel, arrow) , but the changes in total b-catenin level were less prominent than those in ABC. As a consequence, the relative change in active relative to total b-catenin seemed clear. Given this, and our findings that TSH increased Wnt-1 levels in FRTL-5 thyrocytes (most likely through transcriptional regulation), we hypothesized that TSH would increase b-catenin levels in FRTL-5 cells. Remarkably, TSH caused a pronounced decrease in cellular ABC protein levels (Fig. 2c,  arrow) , and also a slight decrease in total b-catenin levels (Fig. 2b, arrow) . Of note in these experiments, the lower antibody reactive complex that was detected in the western blots ( Fig. 2a and c) was not dependent on Wnt1 transfection (Fig. 2a) , appeared to be unique to FRTL-5 cells (data not shown), and increased with TSH treatment (Fig. 2c) , whereas ABC decreased. Its nature is not known but it is not associated with Wnt-1 overexpression.
The basis for these apparent paradoxical results and their biological significance are the subject of the remaining parts of this report.
Wnt-1 suppresses transcription of the TPO gene in FRTL-5 cells
To investigate the functional significance of activation of the canonical Wnt-1/b-catenin-signaling pathway in FRTL-5 thyroid cells, we measured changes in thyroid-specific gene expression induced by overexpression of b-catenin or Wnt-1 in the FRTL-5 thyrocytes. Transient transfection of FRTL-5 cells with a b-catenin expression vector significantly decreased the amount of TPO RNA when compared with vector (control)-transfected FRTL-5 cells ( Fig. 3a and b) . When LiCl, a GSK3b inhibitor known to increase cellular b-catenin level, was added to transfected FRTL-5 cells, the amount of TPO RNA was further decreased (Fig. 3a and b) . Decreases in TSHR RNA were also observed with overexpression of b-catenin (about 20%, Fig. 3a and b ), but were less prominent than TPO RNA. Of note, Tg RNA levels were not affected by overexpression of b-catenin or by LiCl (Fig. 3a and b) . The decrease in TPO RNA in b-catenin-transfected cells was statistically significant in each replicate experiment (P!0 . 05). The overexpression of b-catenin was confirmed by western blot for total b-catenin in transfected FRTL-5 cells (Fig. 3c) .
Transient transfection of FRTL-5 cells with Wnt-1 expression vector (which increases ABC levels (Fig. 2a) ) also decreased TPO RNA when compared with vector (control)-transfected cells (about 30% , Fig. 4 , lane 2 vs lane 1). This suppressive effect was evident in the presence or absence of TSH (Fig. 4, lanes 2 vs 1 and lanes 6 vs 5 respectively) . LiCl added to transfected FRTL-5 cells further decreased the amount of TPO RNA. RNA levels of TSHR and Tg were not affected by overexpression of Wnt-1 (data not shown). In all experiments, the efficacy of LiCl treatment was verified by confirming increases in the amount of total and 'active' b-catenin in LiCl-treated FRTL-5 cells (data not shown).
To probe whether Wnt-1/b-catenin act transcriptionally to inhibit TPO gene expression and also to get an idea of the molecular mechanism of Wnt-1/b-catenin's inhibitory action, we conducted TPO-promoter reporter assays. In an attempt to grossly separate their activities, three truncations of the human TPO transcriptional regulatory element were created: constructs of 181, 1372, and 6300 bp of 5 0 -flanking region (TPO-181 pSV, TPO-1372 pSV, and TPO-6300 pSV respectively). These were then inserted into a luciferase reporter plasmid and transfected into Wnt-1/b-catenintransfected FRTL-5 cells and vector-transfected cells. Wnt-1 or b-catenin overexpression significantly decreased the promoter activities of all three constructs compared with that of vector-transfected cells (Fig. 5) . Moreover, the suppressive effects were observed both in the presence of TSH (Fig. 5a, 6H condition) or the absence of TSH (Fig. 5b , The locations of multiple cis elements known to play a role in TPO expression, TTF-1, Pax-8, and TTF-2 lie within the 181 bp 5 0 -flanking region ( Fig. 6a ; Francis-Lang et al. 1992 , Zannini et al. 1992 , Aza-Blanc et al. 1993 , Ortiz et al. 1999 . We first sought to determine whether the suppressive effect of Wnt-1/b-catenin was a consequence of Wnt-1/b-catenin inhibition of these thyroid-specific transcription factors. The western blot analyses and EMSAs revealed that Wnt-1 or b-catenin overexpression neither affected the amount of TTF-1, Pax-8, or TTF-2 protein nor did they affect the DNAbinding affinity of TTF-1, Pax-8 or TTF-2 (data not shown).
Since luciferase reporter assays suggested that Wnt-1/ b-catenin affect a transcriptional regulatory event that occurs within 181 bp of the 5 0 -flanking region of the TPO gene (Fig. 5) and EMSAs demonstrated that Wnt-1/b-catenin did not affect TTF-1, TTF-2 and Pax-8 (data not shown), we considered the possibility that the TPO gene might be a target for transcriptional suppression by some other mechanism. The sequence 'CTTTGTT', which is complementary to a core TCF/LEF-binding site 5 0 -A/T A/T CAAAG-3 0 , lies within the 181 bp 5 0 -flanking region of the rat TPO-promoter (between K137 and K129 bp, Fig. 6a ; van de Wetering et al. 1997) . To determine whether the suppressive effect of Wnt-1/ b-catenin was a consequence of Wnt-1/b-catenin effect on the b-catenin/TCF complex, we conducted EMSA (Fig. 6b ). EMSAs were performed using an oligo-nucleotide including the TCF/LEF-binding site sequence in the rat TPO-promoter (5 0 -AGTGGCACCTTTGTTCTGACCAG-3 0 ; binding sequence underlined). As shown in Fig. 6b , a specific and prominent band representing a complex between b-catenin/ TCF complex and the oligonucleotide was identified, as evidenced by i) inhibition of the complex (super-shift) by antibodies to TCF-1 (lane 9, 10) or to 'ABC' (lane 11) and ii) elimination by competition with 100-fold molar excess of unlabeled DNA probe (lane 8). FRTL-5 cells transfected with two different kinds of b-catenin expression vectors (MTbCat and bCat, bCt and bCt 0 respectively) showed increased complex formation (Fig. 6b ; lane 5 and 7) by comparison with their respective controls ( Fig. 6b ; lane 4 and 6 respectively). These data indicate that b-catenin overexpression causes increased DNA binding of b-catenin/TCF complex with a TCF/LEF-binding sequence on the rat TPO-promoter, suggesting that the b-catenin/TCF complex might act as a transcriptional repressor of TPO gene. Of note, Wnt-1 overexpression had no effect on the b-catenin/TCF complex ( Fig. 6b; lane 3 vs lane 2) ; the reason for this is unclear but may relate to the transfection efficiency and resulting minimum increases in b-catenin induced experimentally by this procedure.
Wnt-1 enhances the growth of FRTL-5 cells
We probed the effects of Wnt-1 overexpression on the growth of FRTL-5 cells. Since the transfection efficiency of FRTL-5 cells is very low, regardless of the transfection method utilized; it is difficult to observe any change in growth rate of cells by transient transfection. Accordingly, to evaluate the effect of Wnt-1 on FRTL-5 cell growth, we isolated stable cell lines W B KIM and others . Wnt-1 expression and function in thyrocytes overexpressing Wnt-1. These were isolated by transfection of Wnt-1 expression vector containing a hygromycin-resistance gene as a selection marker into FRTL-5 cells by electroporation and cell cloning. As a control, vector-transfected cell clones were also isolated. Several clones were obtained both for Wnt-1-and for vector-transfected cells; however, for growth rate studies only one representative clone from each group was selected. Clone consistently showing high Wnt-1 mRNA and high Wnt-1 protein expression was selected in Wnt-1-transfected cells, and the opposite was selected in vector-transfected cells. Wnt-1 overexpression was confirmed by northern and western blots (Fig. 7) . Wnt-1 overexpressing clone (W1) had significantly higher growth rate when compared with vector-transfected clone (V3) as determined by MTT assay (Fig. 8) . This enhanced growth rate of Wnt-1 overexpressing cell line was confirmed by cell-cycle analysis using flow cytometry by measuring DNA content of cells stained by propidium iodide. Notably, the percentage of cells in S/G2/M phase was significantly higher in Wnt-1 overexpressing clone (W1) than in vector-transfected clone (V3) both in the presence or absence of TSH (Fig. 9) .
We sought to determine the mechanism of Wnt-1-induced increased growth rate of FRTL-5 cells. Cyclin D1 is known to be one of the target genes of Wnt activation because b-catenin increases the expression of cyclin D1 in colorectal cancer cell lines in vitro (Shtutman et al. 1999 , Tetsu & McCormick 1999 . This forms the basis of involvement of Wnt-pathway activation in growth-promoting effect, especially in colon cancer cells (Polakis 2000) . However, total b-catenin levels were unchanged in Wnt-1 overexpressing clone (W1) as compared with vector-transfected clone (V3; data not shown); this was evidenced in multiple experiments. Interestingly, the levels of 'ABC' (nonphosphorylated Ser-37 and Thr-41 form (van Noort et al. 2002) forming nuclear complex with TCF/LEF factors) were not different between Wnt-1 overexpressing clone (W1) and vector-transfected clone (V3; data not shown). Taken together, these data suggest that the Wnt-1-induced increased growth rate is not regulated by the canonical 'Wnt/b-catenin' pathway. In addition, level of TPO mRNA was not different between W1 and V3 clone (data not shown).
Besides, activating b-catenin, some Wnt proteins can also increase intracellular Ca 2C and subsequently activate PKC in some contexts (Miller et al. 1999 , Sheldahl et al. 1999 , Kremenevskaja et al. 2005 . To determine if PKC is involved in the growth-promoting effect, we investigated the effects of staurosporin, a PKC inhibitor, on the growth of Wnt-1 overexpressing clone (W1). Wnt-1 overexpressing clone (W1) had a significantly higher growth rate than the vectortransfected clone (V3; Fig. 10 ). However, in the presence of staurosporin, the growth rate of Wnt-1 overexpressing clone (W1) was significantly blunted when compared with vectortransfected clone (V3; Fig. 10) . Moreover, the STAT3 phosphorylation on the serine 727 residue (one of the downstream effects of PKC activation), but not on the tyrosine 705 residue, was increased in Wnt-1 overexpressing clone (W1) when compared with vector-transfected clone Fig. 11 ). In addition, these data suggest that activation of PKC and (serine phosphorylation) STAT3 is involved in the growth-stimulating effect exerted by Wnt-1 overexpression in FRTL-5 cells.
Discussion
Using a differentiated thyroid cell line, FRTL-5, we have examined the biological implications of activation of a Wntsignaling pathway. Moreover, we have shown that TSH can increase levels of Wnt-1, apparently and specifically; Wnt-1 overexpression enhances cell growth and relieves transcriptional suppression of the TPO gene. TPO is a critical enzyme for thyroid hormone synthesis in thyrocytes. We have suggested that the growth-promoting effect might involve activation of some components of a noncanonical Wntsignaling pathway, whereas relief of the transcriptional suppression of TPO was mainly through the activation of the Wnt/b-catenin pathway, since Wnt-1's suppressive effect was duplicated by b-catenin overexpression.
In the FRTL-5 cell, TSH increased Wnt-1 protein and RNA levels, but not Wnt-5a or Wnt-3a. TSH also increased Wnt-1 levels should have increased the amount of b-catenin, because Wnt-1 classically activates the canonical Wntsignaling pathway, resulting in b-catenin accumulation (Cadigan & Nusse 1997 , Miller et al. 1999 , Nelson & Nusse 2004 . However, surprisingly, exposure of FRTL-5 cell to TSH paradoxically decreased the amount of b-catenin. The cause of this phenomenon is not clear at this moment, although there are two possibilities that could be considered. First, stimulation of TSH signaling might increase the degradation of b-catenin in FRTL-5 cells through an unknown mechanism. Secondly, Wnt-1 might not be the only functionally important Wnt protein in the FRTL-5 cell. This possibility still exists, although we did exclude the presence of Wnt-3a and Wnt-5a. We did not, however, systematically evaluate the expression of all Wnt proteins in the FRTL-5 cell. Nonetheless, the fact that Wnt-1 protein is upregulated and b-catenin protein is simultaneously downregulated by TSH in FRTL-5 cell appears to have very important biological implications based upon our results. TSH-induced increase in Wnt-1 appears to stimulate growth through activation of a PKC pathway and STAT3, whereas, the 'simultaneous' action of TSH to decrease b-catenin protein relieves transcriptional suppression of a major functional protein, TPO. In this respect, it must be recognized that the thyrocyte is relatively unique in that TSH stimulates both growth and function of the cell. Thus, TSH may use the Wnt-signaling system as one means to 'simultaneously' increase both growth and function of the cell. This could be a new paradigm for explaining the physiological role of Wnt-signaling system in a differentiated mammalian cell.
Most target genes of the canonical Wnt pathway are positively regulated by b-catenin . The mechanism of transcriptional activation might be by the b-catenin/TCF/LEF complex acting directly as a transcriptional activator or by acting to displace a corepressor bound to TCF/LEF (Miller et al. 1999) . Nevertheless, transcription of some genes, such as mouse osteocalcin (Cadigan et al. 2002) or shavenbaby, stripe, decapentaplegic, and daughterless genes of Drosophila (Payre et al. 1999 , Piepenburg et al. 2000 , Yang et al. 2000 , Kahler & Westendorf 2003 is suppressed by activation of the canonical Wnt pathway.
In this study, we found that the rat TPO gene is an example of a gene whose transcription is repressed by b-catenin. Thus, we showed that ABC/TCF-1 complex binds to oligonucleotide including consensus TCF/LEF-binding sequence on TPO-promoter, that this complex increases with b-catenin overexpression in FRTL-5 cells, as measured by EMSA, but there is a 'simultaneous' major decrease in TPO RNA levels and lesser decrease in TSHR RNA. This is the first demonstration that b-catenin/TCF-1 complex acts as a transcriptional repressor by binding directly to the promoter of a target gene. In our study, b-catenin overexpression decreased the amount of mRNA for TPO more prominently than Wnt-1 overexpression, whereas the suppressive activity on TPO-promoter constructs was more remarkable with Wnt-1 overexpression. The cause of this discrepancy is not clear, but once again multiple possibilities exist. First, we examined the effects of Wnt-1 overexpression and those of b-catenin overexpression at the same time point after transfection. The expression vectors for Wnt-1 and b-catenin used in experiments might have different optimal times of expression, thereby causing the discrepancy between the results of northern blot analyses and those of the promoter studies. Secondly, because the efficiency of transfection is very low, it may be an issue of sensitivity in transient transfection experiments using FRTL-5 cells. In EMSA, the fact that NE from Wnt-1 overexpression did not increase complex formation between b-catenin/TCF-1 complex and oligonucleotide containing the TCF/LEF-binding sequence might also be due to the problem of transfection. Thirdly, Wnt-1 'simultaneous' overexpression of the Ca CC /PKC/STAT3 pathway, as in the case of stable transfectant of Wnt-1 shown in this study, might add a confounding effect to a Wnt/bcatenin pathway.
The fact that transcriptional repression of the TPO gene exerted by Wnt-1 overexpression was mainly through the activation of the canonical Wnt pathway (Wnt/b-catenin) is further supported by the results of northern blot analysis of cells exposed to LiCl. LiCl is a potent inhibitor of GSK-3b (KiZ2 mM), a key enzyme involved in degradation of b-catenin, as determined by in vitro assays (Klein & Melton 1996) . LiCl treatment (2 mM) decreased the mRNA for TPO additionally with the overexpression of b-catenin or Wnt-1 regardless of the presence of TSH. This strongly suggests that b-catenin is primarily responsible for the transcriptional repression of TPO by Wnt activation of its canonical signaling pathway.
We evaluated the effects of activation of the Wnt-signaling pathway on the growth of FRTL-5 cell using a stable transfectant that overexpressed Wnt-1. In terms of activation of the Wnt/b-catenin pathway, constitutive b-catenin activity has been considered as the main mechanism of growth stimulation (Miller et al. 1999 , Polakis 2000 , 2002 . This is based on the fact that genes for c-myc and cyclin D1, which are known to promote cell proliferation, are direct targets of b-catenin (He et al. 1998 , Shtutman et al. 1999 , Tetsu & McCormick 1999 . However, the cellular b-catenin level of Wnt-1 overexpressing clone (W1) did not increase at all when compared with nontransfected FRTL-5 cells or to vectortransfected cells, arguing against the role of the canonical Wnt pathway in growth stimulation.
Further, as the increase in growth rate of W1 clone was abrogated by staurosporin, a PKC inhibitor, activation of the Wnt/Ca CC pathway is a potential candidate for the growth stimulation in Wnt-1-transfected cells. The mechanism of Wnt/Ca CC pathway activation leading to PKC activation is not well-documented currently, although there have been some reports that the Wnt signal at the cell membrane is recognized by specific subtypes of frizzled receptors (Sheldahl et al. 1999) and may function through activation of heterotrimeric G-proteins (Slusarski et al. 1997 , Sheldahl et al. 1999 . The phenomenon of a decrease in ABC protein both in the Wnt-1-transfected cells (W1) and in the vectortransfected cells (V3) cannot be explained at this time. Nonetheless, this still suggests that b-catenin does not have an important role in growth regulation of the FRTL-5 cell.
We found that activation of the Wnt-signaling pathway is associated with STAT3 activation. STAT3 is of growing interest as an oncogene involved in cell-cycle progression, cellular transformation, and prevention of apoptosis (Bowman et al. 2000 , Calo et al. 2003 . Constitutively, activated STAT3 and STAT5 proteins are found in many types of human cancers and cancer cell lines. Genes for Bcl-x L , cyclin D1, p21 WAF1/CIP1 , c-myc are known to be the targets of constitutively activated STATs (Bowman et al. 2000 , Calo et al. 2003 . In the case of STAT3, tyrosine 705 (Tyr 705) and serine 727 (Ser 727) are the important phosphorylation sites. We found that the amount of STAT3 protein phosphorylated on serine 727 was increased in the Wnt-1 overexpressing stable transfectant W1 clone, when compared with nontransfected FRTL-5 cells or to a vector-transfected clone. The increase in Ser727 phosphorylation of STAT3 seems not to be through the TSH/cAMP-signaling pathway, as TSH induces phosphorylation at both sites, Tyr 705 and Ser 727 in FRTL-5 cells (Park et al. 2000) . As there is evidence for a role of PKC in serine phosphorylation of STAT3 (Jain et al. 1999) , it is plausible that the Wnt-1 activation of the Wnt/Ca CC pathway leading to PKC activation increased serine phosphorylation of STAT3 in the Wnt-1 overexpressing cell. Based on the fact that protein levels of ABC did not increase and serine phosphorylated STAT3 increased in the Wnt-1 overexpressing cells, we suggest that the activation of the noncanonical Wnt pathway, involving activation of PKC and serine phosphorylation of STAT3, is the main mechanism of the growth-enhancing effect observed in this cell.
In sum, by overexpressing Wnt-1 and b-catenin in FRTL-5 cells, we showed that activation of the Wnt-signaling pathway enhances cellular growth probably through a PKC pathway, which involves increased serine phosphorylation of STAT3. We also showed that activation of the Wnt/b-catenin pathway can suppress transcription of the TPO gene by increased binding of b-catenin/TCF-1 complex to the TPO-promoter. TSH-induced decrease in b-catenin would relieve this suppression consistent with the well-known ability of TSH to increase TPO RNA levels in FRTL-5 cells.
